Learn More
Description
CaptureSelect IgE Affinity Matrix has been designed specifically for the purification of human IgE (immunoglobuline E) from recombinant and plasma sources.
Features of this affinity matrix include:
- Purification of human IgE, binding different recombinant IgE forms
- Efficient removal of host cell proteins (HCP) and IgE aggregates
- Excellent scalability
- Non–animal-derived
Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Main characteristics
- Matrix: agarose-based, epoxide-activated
- Average particle size: 65 ± 10 μm
- Ligand: CaptureSelect IgE affinity ligand
- Ligand coupling method: aldehyde coupling
- Binding capacity: >5 mg/mL resin
- Elution conditions: 50 mM sodium citrate, 150 mM NaCl, pH 3.5
- Flow characteristics: 50–200 cm/h (up to 2 bar)
- Formulation buffer: 20% (v/v) ethanol
Spécification
Spécification
| Capacité de liaison | >5 mg/mL resin |
| Débit | 50 to 200 cm/hr. (Up to 2 bar) |
| Matrice | Agarose-based, epoxide-activated |
| Contenu et stockage | Store at 2°C to 8°C. |
| Conditions d’expédition | Room Temperature |
| Granulométrie | 65 ±10 μm |
| Forme | Chromatography Media |
| Gamme de produits | CaptureSelect |
| Quantité | 5 ml |
| Type | Affinity Matrix |
| Afficher plus |
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.